NCT04457843

Brief Summary

Up tp now, disease activity of COPD patients in their home environment has usually been recorded by questionnaires (e.g. COPD assessment test). Digital multifactorial measurements, via the "mobile COPD Status test" app, offer a new way of displaying disease activity. However, there is no independent study that has examined whether digitally collected parameters correlate with the common used measurement instruments for COPD patients (both in cross-sectional and longitudinal course). The aim of this exploratory study is to investigate the correlation between the mobile COPD Status test (mCST App, KAIA Health) and a conventional collected clinical data set of routine measurements as well as the subjective symptoms and activity perception of COPD patients in their home environment, with and without exacerbation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 7, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

August 21, 2020

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

2.9 years

First QC Date

June 4, 2020

Last Update Submit

April 28, 2025

Conditions

Keywords

Telehealthdisease progressiondisease activity

Outcome Measures

Primary Outcomes (2)

  • Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)

    Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)

    Visit 1 (Day 0)

  • Correlation between usual physical exercise tests and exercise test measured via mobile COPD status test app (mCST)

    Correlation between the 6-minute walk test distance (clinical routine) and the number of repetitions of the 1-minute sit-to-stand-test (mCST app)

    if applicable Visit 2 (Day 14)

Secondary Outcomes (8)

  • Correlation between COPD Assessment test and perception of disease activity measured via mobile COPD status test app (mCST)

    weekly up to 26 weeks (Visit 1 to Visit 26)

  • Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)

    Visit 1 (Day 0)

  • Correlation between modified medical research scale (mMRc) and perception of dyspnea measured via mobile COPD status test app (mCST)

    if applicable Visit 2 (Day 14)

  • Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)

    Visit 1 (Day 0)

  • Correlation between lung function parameters and inspiratory-/expiratory duration measured via mobile COPD status test app (mCST)

    if applicable Visit 2 (Day 14)

  • +3 more secondary outcomes

Study Arms (1)

COPD patients

Other: usual medical care

Interventions

Prospective monitoring of clinical Outcomes and digital collected outcomes via the mobile COPD staus test app.

COPD patients

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

COPD patients

You may qualify if:

  • hospitalisation at Schoen Klinik Berchtesgadener Land or Klinikum Nuremberg
  • Chronic obstructive pulmonary disease GOLD A-D
  • sufficient german language and samrtphone skills to understand the mCST app
  • sufficient good WLAN Connection in the domestic environment

You may not qualify if:

  • presence of comorbidities which could interfere the course of the trial (e.g. cognitive deficits, neurological or orthopedic diseases)
  • significant mental illness, legal incapacity or limited legal capacity
  • patients who are unable or unwilling to perform the study activities acording to the protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Klinikum Nürnberg, Klinik für Innere Medizin3, Schwerpunkt Pneumologie

Nuremberg, Germany

Location

Klinikum Berchtesgadener Land, Schön Kliniken

Schönau am Königssee, 83471, Germany

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveDisease Progression

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor for pulmonary rehabilitation

Study Record Dates

First Submitted

June 4, 2020

First Posted

July 7, 2020

Study Start

August 21, 2020

Primary Completion

July 31, 2023

Study Completion

July 31, 2023

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations